基尿症中随时间推移的氨耐受性:系统性审查和元分析
Alex Pinto1,2, Fatma Ilgaz3, Sharon Evans1
1Department of Dietetics, Birmingham Women's and Children's Hospital, Birmingham B4 6NH, UK.
Nutrients
|August 26, 2023
概括
基尿症 (PKU) 患者的自然蛋白质和氨耐受性随着年龄的增长而增加,在青春期达到顶峰. 这种耐受性对于终身管理PKU至关重要.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 营养科学 营养科学
- 人类生理学 人类生理学
背景情况:
- 基尿症 (PKU) 管理需要仔细控制氨 (Phe) 摄入量.
- 在PKU中自然蛋白质耐受性在寿命之间有所不同,但终身数据有限.
- 了解终身耐受性是PKU患者最佳管理的关键.
研究的目的:
- 系统地审查和分析Phe和自然蛋白质耐受性的变化,从出生到成年期在得到良好控制的PKU患者.
- 为了提供对整个PKU个体的饮食耐受性在整个生命周期的进展的见解.
主要方法:
- 对2020年7月之前发表的研究的五个电子数据库进行系统审查.
- 包括37篇文章 (n=2464名患者) 符合资格标准.
- 对18项选定的研究进行元分析,以量化耐受性变化.
主要成果:
- 费和天然蛋白质摄入量从婴儿期逐渐增加到6岁.
- 耐受性在童年后期和青春期显著增加,从生命的第一年开始增加了三倍以上.
- 成人的天然蛋白质耐受性在17岁左右达到顶峰,并保持稳定,尽管成人数据有限.
结论:
- 在PKU中,Phe和天然蛋白质耐受性随着年龄的增长而增加,特别是在青春期,在青春期晚期达到峰值水平.
- 研究结果表明,在PKU患者一生中,需要采用动态饮食管理方法.
- 研究之间的高度异质性需要谨慎的解释,特别是对于成人数据.
相关概念视频
Inborn Errors of Metabolism
194
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
194
Overview of Protein Metabolism
1.3K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.3K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
195
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
195
Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K
Amino Acid Biosynthetic Pathways
36
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
36


